Source: Google NewsPublished on 2023-03-17
Related Articles:
- Parkinson's Disease News - Editor's Picks (Archive 2016.09) October 15, 2016 Newsfeed: PD News PD Research News PD Fitness News PD Boxing News PD Web Articles PD Blogs PD Editor's Picks PD Twitter Newsfeed ‘The Terrorist Inside My Husband’s Brain’: Robin Williams’ Widow Details His Disease – Live ScienceLive Science'The Terrorist Inside My Husband's Brain': Robin Williams' Widow Details His DiseaseLive ScienceBut Robin Williams was not diagnosed with Lewy body disease…
- Monthly Research Review – September 2022 September 30, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during September 2022. The post is divided into 10 parts based on the type of research: Top 6 pieces of Parkinson’s news Articles of general interest Basic biology…
- World Parkinson Congress 2023 – Can you see yourself there? March 14, 2023 What is the World Parkinson Congress? The World Parkinson Congress (WPC) is an international forum for dialogue on the latest scientific discoveries, medical practices, and care partner initiatives related to Parkinson’s disease (PD). WPC takes place approximately every three years (with a recent delay due to COVID-19), each time in a different location around the world. A unique aspect of…
- Reflections on World Parkinson Congress 2016 September 28, 2016 This was my first time attending the World Parkinson Congress. I suppose that is understandable considering that the congress is held every 3 years, and it has only been 2-1/2 years since my diagnosis. Prior to that, PD was not on my radar. As a congress newbie PwP, I thought I would share a few of my thoughts and "take-aways" from…
- Monthly Research Review – June 2021 June 30, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during June 2021. The post is divided into 10 parts based on the type of research: Top 4 pieces of Parkinson’s news Articles of general interest Basic biology…
- IRL752 May Safely Manage Treatment-resistant Symptoms in Parkinson’s Dementia, Trial Shows March 26, 2020 Treatment with IRLAB Therapeutics‘ small molecule IRL752 is safe and well-tolerated by Parkinson’s disease patients with dementia, and may help manage symptoms that are unresponsive to levodopa, results from a Phase 2a trial show. In particular, the treatment was found to reduce apathy, improve balance, and decrease the risk of falls. Planning and executive function also seem to improve with IRL752.…
- Phase 3 Trial Will Examine Mesdopetam as Treatment for Levodopa-induced Dyskinesia June 11, 2020 Integrative Research Laboratories (IRLAB) is planning a Phase 2b/3 clinical trial of its investigational therapy mesdopetam (IRL790) to evaluate the therapy’s ability to reduce levodopa-induced dyskinesia (involuntary muscle movements) in people with Parkinson’s disease. IRLAB is in the process of preparing applications to relevant regulatory agencies, with plans to start the trial in the second half of this year. “The strategy…
- June 2, 2019 - Parkinson's Weekly Update June 1, 2019 Weekly Update - Highlights include: World Parkinson Congress 2019 heads to Kyoto, Japan for the epic battle of "Parkinson's Disease vs. Chopsticks - Will We Go Home Hungry?"; focused ultrasound and PD; NIH awards $3 million grant for 5-year PD exercise study; deteriorating financial skills, dementia and brain plaques; hockey pucks for Parkinson's; inspiring people with PD; how DBS changes…
- Highlights from the Movement Disorder Society Virtual Congress 2021 October 5, 2021 Every year the International Parkinson and Movement Disorder Society (MDS) holds a conference and every year APDA is there, learning about the newest research and sharing our resources with the wider Parkinson’s disease (PD) community. The MDS Congress is the preeminent gathering of medical professionals from around the world who are dedicated to PD and other movement disorders. So much…
- Monthly Research Review: January 2022 January 31, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during January 2022. The post is divided into 10 parts based on the type of research: Top 6 pieces of Parkinson’s news Articles of general interest Basic biology…
- 15 Patient Ambassadors Tapped for 2022 World Parkinson Congress March 16, 2020 A diverse group of 15 Parkinson’s (PD) patients — all described as “invaluable” advocates — have been appointed as Ambassadors for the 6th World Parkinson Congress (WPC), to be held in Spain in June 2022. Chosen by the World Parkinson Coalition, these new ambassadors represent 11 countries and, collectively, have more than 100 years of experience living with the neurodegenerative disease.…
- The World Parkinson Congress - Bringing the PD Community Together (Interview with Eli Pollard) June 15, 2018 Watch Sarah's Interview with Eli Pollard: Who is the World Parkinson Coalition? What is the World Parkinson Congress? Every three years the World Parkinson Congress draws world leaders in basic and clinical science, care, and advocacy from across the globe. The World Parkinson Coalition is a global Parkinson's non-profit that was formed in 2004 with encouragement from the head of…
- The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s. It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
- Ipsen Bets $363 Million on IRLAB's Phase II Parkinson's Drug - BioSpace July 16, 2021 Ipsen Bets $363 Million on IRLAB's Phase II Parkinson's Drug BioSpace
- IRLAB Publishes Interim Report for July 1 – September 30, 2021 - BioSpace November 10, 2021 IRLAB Publishes Interim Report for July 1 – September 30, 2021 BioSpace
- IRLAB Obtains Regulatory Approval to Conduct Phase IIb Study With Pirepemat – One Step Closer To Improving Balance and Reducing Fall Injuries For People Living With Parkinson's Disease - BioSpace December 22, 2021 IRLAB Obtains Regulatory Approval to Conduct Phase IIb Study With Pirepemat – One Step Closer To Improving Balance and Reducing Fall Injuries For People Living With Parkinson's Disease BioSpace
- Board Member Leaves IRLAB for Another Assignment - BioSpace January 1, 2022 Board Member Leaves IRLAB for Another Assignment BioSpace
- IRLAB's Year-End Report January 1 - December 31, 2021 - BioSpace February 23, 2022 IRLAB's Year-End Report January 1 - December 31, 2021 BioSpace
- Invitation to IRLAB's Capital Markets Day 2022– Insights into our Growth Strategy - BioSpace February 23, 2022 Invitation to IRLAB's Capital Markets Day 2022– Insights into our Growth Strategy BioSpace
- Welcome to IRLAB's Capital Markets Day 2022 - BioSpace March 18, 2022 Welcome to IRLAB's Capital Markets Day 2022 BioSpace
- IRLAB Nominates New Candidate Drug, IRL757, to Treat Apathy in Neurological Disorders - BioSpace March 21, 2022 IRLAB Nominates New Candidate Drug, IRL757, to Treat Apathy in Neurological Disorders BioSpace
- IRLAB Interim Report January – March, 2022 - BioSpace May 11, 2022 IRLAB Interim Report January – March, 2022 BioSpace